फलो गर्नुहोस्
Englishनेपाली
← पछाडि
Antidotes and other Substances used In Poisonings

Phenobarbital

Antidotes and other Substances used In Poisonings
Injection · Tablet200mg · 15 mg · 30 mg · 60 mg
Phenobarbital नेपालको National List of Essential Medicines (NLEM, Sixth Revision 2021) मा रहेको औषधि हो। यो Antidotes and other Substances used In Poisonings > 4.2 Specific (complementary list) वर्गमा पर्छ।
सामान्य नाम (Generic name)phenobarbital
वर्ग (Therapeutic class)Antidotes and other Substances used In Poisonings > 4.2 Specific (complementary list)
रूप र शक्ति (Form & strength, NLEM)Injection: 200mg (sodium)/ ml; Tablet: 15 mg, 30 mg, 60 mg
स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog
स्रोतU.S. FDA-approved label via DailyMed (label effective 12 Oct 2023) · National List of Essential Medicines, Nepal (2021) · अमेरिकी लेबलिङ नेपालको DDA-स्वीकृत लेबलिङ र स्थानीय प्रिस्क्राइबिङ अभ्यासभन्दा फरक हुन सक्छ।

What it's for

Anticonvulsant- For the treatment of generalized and partial seizures.

From the U.S. FDA-approved label for Phenobarbital. Full label: DailyMed.

Anticonvulsant- For the treatment of generalized and partial seizures.

From the U.S. FDA-approved label for Phenobarbital. Full label: DailyMed.

The dose of phenobarbital must be individualized with full knowledge of it particular characteristics. Factors of consideration are the patients age, weight, and condition. Sedation For sedation, the drug may be administered in single doses of 30 to 120 mg repeated at intervals; frequency will be determined by the patient's response.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Phenobarbital is contraindicated in patients who are hypersensitive to barbiturates, in patients with a history of manifest or latent porphyria, and in patients with marked impairment of liver function or respiratory disease in which dyspnea or obstruction is evident.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Habit Forming Phenobarbital may be habit forming. Tolerance and psychological and physical dependence may occur with continued use ( see DRUG ABUSE AND DEPENDENCE and Pharmacokinetics under CLINICAL PHARMACOLOGY). Patients who have psychologic dependence on barbiturates may increase the dosage or decrease the dosage interval without consulting a physician and may subsequently develop a physical dependence on barbiturates.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions have been reported: CNS Depression - Residual sedation or "hangover", drowsiness, lethargy, and vertigo. Emotional disturbances and phobias may be accentuated. In some persons, barbiturates such as phenobarbital repeatedly produce excitement rather than depression, and the patient may appear to be inebriated. Irritability and hyperactivity can occur in children.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

Shake well before use. Keep tightly closed. Store at 20° - 25°C (68° - 77°F).

Storage information from the U.S. FDA-approved label.

Browse A–Z5ABCDEFGHIJKLMNOPQRSTUVWXYZ

अन्तरक्रिया (Interactions)

अन्य औषधि, खाना र जडीबुटी उत्पादनले Phenobarbital को काम बदल्न सक्छन्। Phenobarbital को FDA लेबलले यसको अन्तरक्रिया खण्डमा ८ अन्य औषधिको नाम लिएको छ।

Phenobarbital का अन्तरक्रिया हेर्नुहोस् →

एपमा औषधि खोज्नुहोस् फार्मेसी खोज्नुहोस्
+ सुरक्षा जानकारी

यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधि प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ। NLEM सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।

यो औषधि सेयर गर्नुहोस्
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.